EML
Home
Recent Updates
Favourites
Search
Directory
Guidelines
Medicines
Tools
About
Feedback
Disclaimer
Directory
Guidelines
Search
Medicines
Tools
Antineoplastic and Immunomodulating Agents
Methotrexate
ATC Code
Indication
NEMLC Recommendation
Review Indicators
Date Ratified
ATC CODE
L01BA01
INDICATION
Adjuvant breast cancer.
NEMLC RECOMMENDATION
Approved
(Cyclophosphamide plus methotrexate plus fluoro-uracil (CMF)).
REVIEW INDICATORS
n/a
DATE RATIFIED
27 November 2008